Cynata Therapeutics achieves progress in stem cell technology – Proactive Investors USA & Canada
Proactive Investors USA & Canada |
Cynata Therapeutics achieves progress in stem cell technology
Proactive Investors USA & Canada Cynata Therapeutics (ASX:CYP) has received the Notice of Allowance from the U.S. patent office for a patent application tied to its proprietary Cymerus™ stem cell technology. This patent application covers an important element of Cynata’s stem cell … |
ModernMedicine |
Tapping gene therapy potential for inherited retinal diseases
ModernMedicine Though gene therapy technology already exists to treat most inherited retinal disease, the current challenge is to drive down the costs of implementing the technology—thus availing more patients with the benefits of treatments and possibly prevent … |
Genetic Engineering & Biotechnology News |
CRISPR Reverses Huntington’s Disease in Mice
Genetic Engineering & Biotechnology News The potential of genome-editing techniques, such as CRISPR/Cas9, to alleviate disease burden has ignited the imagination for thousands of researchers looking for new therapeutic strategies. Scientists were very quickly able to show that this gene … |
|
Firefly gene illuminates ability of optimized CRISPR–Cpf1 to efficiently edit human genome
Science Daily Professor Michael Farzan, co-chair of TSRI’s Department of Immunology and Microbiology, and TSRI Research Associate Guocai Zhong improved the efficiency of the CRISPR–Cpf1 gene editing system by incorporating guide RNAs with “multiplexing” … |
|
Firefly gene illuminates ability of optimized CRISPR–Cpf1 to efficiently edit human genome
Science Daily Professor Michael Farzan, co-chair of TSRI’s Department of Immunology and Microbiology, and TSRI Research Associate Guocai Zhong improved the efficiency of the CRISPR–Cpf1 gene editing system by incorporating guide RNAs with “multiplexing” … |